Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Phase I/II Trial of Granulocyte-augmented Cord Blood Transplantation for Young Adults With Very Poor Risk Acute Myeloid Leukaemia.

NCT07372885 is registered in ClinicalTrials.gov with University of Manchester as lead sponsor.

NCT NCT07372885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07372885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Phase I/II Trial of Granulocyte-augmented Cord Blood Transplantation for Young Adults With Very Poor Risk Acute Myeloid Leukaemia.
Lead sponsor
University of Manchester
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
February 9, 2026
Completion date
December 31, 2029
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, cellular therapy, cord blood stem cell transplantation, stem cell transplantation, stem cell transplantation, hematopoietic